Mesa Laboratories, Inc.
MLAB · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $240,978 | $216,187 | $219,080 | $184,335 |
| % Growth | 11.5% | -1.3% | 18.8% | – |
| Cost of Goods Sold | $90,108 | $82,937 | $85,387 | $75,245 |
| Gross Profit | $150,870 | $133,250 | $133,693 | $109,090 |
| % Margin | 62.6% | 61.6% | 61% | 59.2% |
| R&D Expenses | $19,518 | $19,300 | $20,490 | $15,767 |
| G&A Expenses | $73,333 | $72,867 | $72,444 | $60,311 |
| SG&A Expenses | $115,016 | $111,492 | $109,883 | $88,621 |
| Sales & Mktg Exp. | $41,683 | $38,625 | $37,439 | $28,310 |
| Other Operating Expenses | $0 | $274,533 | $0 | $0 |
| Operating Expenses | $134,534 | $405,325 | $130,373 | $104,388 |
| Operating Income | $16,336 | -$272,075 | $3,320 | $4,702 |
| % Margin | 6.8% | -125.9% | 1.5% | 2.6% |
| Other Income/Exp. Net | -$10,375 | -$3,573 | -$3,709 | -$1,128 |
| Pre-Tax Income | $5,961 | -$275,648 | -$389 | $3,574 |
| Tax Expense | $7,935 | -$21,402 | -$1,319 | $1,703 |
| Net Income | -$1,974 | -$254,246 | $930 | $1,871 |
| % Margin | -0.8% | -117.6% | 0.4% | 1% |
| EPS | -0.36 | -47.2 | 0.17 | 0.36 |
| % Growth | 99.2% | -27,864.7% | -52.8% | – |
| EPS Diluted | -0.36 | -47.2 | 0.17 | 0.35 |
| Weighted Avg Shares Out | 5,429 | 5,386 | 5,321 | 5,212 |
| Weighted Avg Shares Out Dil | 5,429 | 5,386 | 5,361 | 5,335 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $11,859 | $5,697 | $4,770 | $3,885 |
| Depreciation & Amortization | $24,527 | $31,574 | $33,134 | $25,068 |
| EBITDA | $42,347 | -$238,377 | $37,515 | $32,527 |
| % Margin | 17.6% | -110.3% | 17.1% | 17.6% |